$2.29T
Total marketcap
$390.66B
Total volume
BTC 55.58%     ETH 9.33%
Dominance

Elekta AB (publ) EKTAY Stock

$5.63   -2.256946%
Add to favorites
Market Cap
$2.15B
LOW - HIGH [24H]
$5.62 - $5.62
VOLUME [24H]
$1.00
P/E Ratio
0
Earnings per share
-$0.15
ISIN
US28617Y1010
Price   Prediction

Elekta AB (publ) Price Chart

Sorry, that's all we've gotfor now...

Elekta AB (publ) EKTAY Financial and Trading Overview

Elekta AB (publ) stock price 5.63 USD
Previous Close 5.64 USD
Open 5.66 USD
Bid 5.61 USD x 476400
Ask 5.65 USD x 456400
Day's Range 5.6 - 5.66 USD
52 Week Range 4.35 - 6.93 USD
Volume 1.96K USD
Avg. Volume 1.52K USD
Market Cap 2.14B USD
Beta (5Y Monthly) 0.963
PE Ratio (TTM) N/A
EPS (TTM) -0.15 USD
Forward Dividend & Yield 0.26 (4.48%)
Ex-Dividend Date March 6, 2026
1y Target Est N/A

EKTAY Valuation Measures

Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) 0.27
Price/Sales (ttm) N/A
Price/Book (mrq) 0.2532447
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Elekta AB (publ) Stock Price History

Beta (5Y Monthly) 0.963
52-Week Change 11.00%
S&P500 52-Week Change 27.69%
52 Week High 6.93 USD
52 Week Low 4.35 USD
50-Day Moving Average 6 USD
200-Day Moving Average 5.69 USD

EKTAY Share Statistics

Avg. Volume (3 month) 1.52K USD
Avg. Daily Volume (10-Days) 1.74K USD
Shares Outstanding 367.1M
Float 318.7M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 0%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield 344.00%
Payout Ratio 3.2757
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends April 30, 2026
Most Recent Quarter (mrq) April 30, 2026
Next Fiscal Year End April 30, 2027

Profitability

Profit Margin -3.10%
Operating Margin (ttm) 0%
Gross Margin 38.38%
EBITDA Margin 8.57%

Management Effectiveness

Return on Assets (ttm) 2.48%
Return on Equity (ttm) -6.45%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) -7.59%
Gross Profit (ttm) N/A
EBITDA 1.43B USD
Net Income Avi to Common (ttm) N/A
Diluted EPS (ttm) -0.15
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) N/A
Total Cash Per Share (mrq) N/A
Total Debt (mrq) N/A
Total Debt/Equity (mrq) 102.56 USD
Current Ratio (mrq) 0.87
Book Value Per Share (mrq) 22.113

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) 1.12B USD

Profile of Elekta AB (publ)

Country United States
State N/A
City Stockholm
Address Hagaplan 4
ZIP 113 68
Phone 46 8 58 72 54 00
Website https://www.elekta.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 4353

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as well as quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit, a gamma knife system; and Leksell GammaPlan, a treatment planning and management software, as well as Elekta ONE, an oncology software suite. In addition, the company offers brachytherapy products, including Elekta Studio, an image-guided brachytherapy solution; ImagingRing for dynamic imaging; Oncentra Brachy, a smart tool that facilitates repetitive tasks; Elekta Xoft Axxent and electronic brachytherapy systems; Elekta Geneva, an applicator for cervical cancer patients; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Venezia applicator that enables the oncologist to treat locally advanced cervical cancer. Further, it provides Leksell Vantage Stereotactic System, a neurosurgery product; Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. Additionally, the company offers Elekta Care support services; Elekta Care 360, which provides a range of clinical and professional services; Elekta Care Learning that offers in-person and digital training courses on radiotherapy; Elekta Care Community, a self-help center; Elekta Partner Community, an online self-service portal; and Elekta Intellimax for predictive maintenance. Elekta AB (publ) was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Q&A For Elekta AB (publ) Stock

What is a current EKTAY stock price?

Elekta AB (publ) EKTAY stock price today per share is 5.63 USD.

How to purchase Elekta AB (publ) stock?

You can buy EKTAY shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Elekta AB (publ)?

The stock symbol or ticker of Elekta AB (publ) is EKTAY.

Which industry does the Elekta AB (publ) company belong to?

The Elekta AB (publ) industry is Medical Devices.

How many shares does Elekta AB (publ) have in circulation?

The max supply of Elekta AB (publ) shares is 382.08M.

What is Elekta AB (publ) Price to Earnings Ratio (PE Ratio)?

Elekta AB (publ) PE Ratio is now.

What was Elekta AB (publ) earnings per share over the trailing 12 months (TTM)?

Elekta AB (publ) EPS is -0.15 USD over the trailing 12 months.

Which sector does the Elekta AB (publ) company belong to?

The Elekta AB (publ) sector is Healthcare.

Select currency